Association of systemic lupus erythematosus autoantibody diversity with breast cancer protection

BACKGROUND: Epidemiologic data suggest that patients with systemic lupus erythematosus (SLE) have a lower risk of breast cancer than women in the general population. In light of mechanistic studies suggesting that anti-DNA antibodies have anti-cancer effects, we sought to examine breast cancer risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Ami A., Igusa, Takeru, Goldman, Daniel, Li, Jessica, Casciola-Rosen, Livia, Rosen, Antony, Petri, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905617/
https://www.ncbi.nlm.nih.gov/pubmed/33632283
http://dx.doi.org/10.1186/s13075-021-02449-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905617/
https://www.ncbi.nlm.nih.gov/pubmed/33632283
http://dx.doi.org/10.1186/s13075-021-02449-3

Ejemplares similares